Bioorganic & Medicinal Chemistry

The Tetrahedron Journal for Research at the Interface of Chemistry and Biology

Bioorganic & Medicinal Chemistry - ISSN 0968-0896
Source Normalized Impact per Paper (SNIP): 0.969 Source Normalized Impact per Paper (SNIP):
SNIP measures contextual citation impact by weighting citations based on the total number of citations in a subject field.
SCImago Journal Rank (SJR): 0.978 SCImago Journal Rank (SJR):
SJR is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and a qualitative measure of the journal’s impact.
Impact Factor: 2.93 (2016) Impact Factor:
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
5 Year Impact Factor: 2.88 (2016) Five-Year Impact Factor:
To calculate the five year Impact Factor, citations are counted in 2016 to the previous five years and divided by the source items published in the previous five years.
© 2017 Journal Citation Reports ® (Clarivate Analytics, 2017)
Volumes: Volume 26
Issues: 24 issues
ISSN: 09680896

Institutional Subscription

Tax/VAT will be calculated at check-out Price includes VAT (GST)
eJournal

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents.

The Journal welcomes papers on:

  • the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets
  • the reporting of the discovery, design or optimization of potent new compounds or biological agents
  • the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data
  • the reporting of "first-in-class" new therapeutic compounds
  • the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism
  • methodological advances that are chemistry-based and which significantly impact on medicine or biology
  • the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states
  • the development of materials for specific therapeutic targeting


All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.